MGMT-Unmethylated Glioblastoma
Oncology
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target MGMT-Unmethylated Glioblastoma?
There are 3 clinical trials targeting MGMT-Unmethylated Glioblastoma tracked by BioSniper.
What is the prevalence of MGMT-Unmethylated Glioblastoma?
The estimated prevalence of MGMT-Unmethylated Glioblastoma is approximately 3.2 per 100,000 population.
Deep-dive into MGMT-Unmethylated Glioblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis